All In Biotech

Free tool

FAERS Monitor: Elcys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210660 or its brand name (Elcys, Cysteine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

25

Serious

24

96% of reports

Hospitalization

13

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hallucination6
  • pneumonia4
  • erythema multiforme3
  • malaise3
  • food craving2
  • intentional product use issue2
  • thirst2
  • accidental exposure1
  • altered state of consciousness1
  • apnoea1
  • atrial fibrillation1
  • body temperature decreased1
  • bronchial secretion retention1
  • candida pneumonia1
  • carnitine deficiency1

Reports by year received

View as table
YearReports
20051
20071
20081
20101
20127
20131
20161
20173
20182
20201
20213
20232
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,134 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
carnitine deficiency14953.9721.71,230
candida pneumonia12615.4382.1651
bronchial secretion retention1661.696.9164
food craving2319.984.6357
erythema multiformeSignal3270.793.6559
accidental exposure1202.129.650
apnoea1108.115.826
thirst294.224.9103
body temperature decreased185.512.520
hallucinationSignal667.033.3328
altered state of consciousness138.85.79
intentional product use issue219.25.119
pneumoniaSignal410.44.226
atrial fibrillation18.61.31
malaiseSignal35.82.08

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.